Biology and Evolution of Microorganisms

The Biology and Evolution of Microorganisms Group, whose head is Dr. Rafael Cantón and which is made up of nine other principal investigators as well as numerous pre- and post-doctoral researchers, technicians and other healthcare personnel, has participated in the last 5 years in 17 national and international research projects and in 15 contracts with pharmaceutical companies or companies dedicated to in vitro diagnostics. During this period of time this work has resulted in more than 190 publications in national and international journals with a high impact index and more than 11 doctoral theses. Likewise, more than 400 communications have been presented at numerous national and international congresses. And all this always seeking the highest excellence in the fields of population biology, antibiotic resistance, respiratory infection, microbiota, metagenomics and HIV.

2023 Activity indicators

9 competitive European projects: IMI, H2020, HE, ERC-STG, EU4HEALTH, JPIAMR
16 national competitive led projects: ISCIII. CAM, FIBioHRC
17 private diagnostic testing projects
9 clinical led trials
16 competitive HR contracts
92 publications
FI: 699.12
Q1 publications:38 (41%)
D1 publications: 19 (21%)
3 thesis
4 awards
Project evaluators: 7 PI
Members of editorial committees: 5 PI
1 intellectual property registration (application number: 2305114294344), a co-development and licensing agreement
1 clinical guide, 6 technical reports and 2 consensus documents
8 Recommendarion documents: ICOMEM, JPIAMR y SEIMC
17 actions with an impact on society: interviews in the media, news in the press, charity market, Research Night, classes, conferences, among others)
10 visitors hosted and 35 months of stay:
- UCM and UAM
- Lozano Blesa Hospital in Zaragoza
- General Hospital in Alicante Vírgen del Rocío Hospital in Seville
- Univ. CEMIC Hospital (Argentina)
+3 months of stay in foreign centers:
- Faculty of Marine Sciences and Biological Resources, University of Antofagasta (Chile)

Milestones

Preparation of reports and guides for international agencies (report by the UNEP, WHO, FAO and OIE quadripartite that reviews the available evidence with a OneHealth perspective on the environmental aspects of antimicrobial resistance) and national agencies (PROA Certification Guide with the AEMPS) and scientific societies (Guide for the treatment of infections with multi-resistant Gram-negative bacilli from the SEIMC).
Integration into the FORTALECE Project of the IRYCIS/ISCIII that seeks to strengthen emerging and established groups through the development of innovative therapies and actions for transfer to the clinic.
Raising resources through competitive calls for international (ERADIAMR) and national projects of the ISCIII (PI23/01036, PI23/01945, PI23/00175 and PI23/01194), FOR23/00046 FORTALECE, IM_MISIÓN22), including HR 1 Rio Hortega, 1 "César Nombela" research talent attraction contract of the Community of Madrid and agreements with pharmaceutical, biotechnology and diagnostic companies (QUANTAMATRIX, SHIONOGI, VIRCELL, Becton Dickinson, Mikrobiomik and Canal de Isabel II) and Foundations (Alonso Family).
Granting of two new JPIAMR networks for networking of European groups: TEAPOTS "Tools for the Epidemiology of AMR Plasmids, One-Health Transmission and Surveillance" and ISARPAE "Improving surveillance of antibiotic-resistant Pseudomonas aeruginosa in Europe").
Participation in international Global Health programs in collaboration with local Ministries of Health for the development of projects to improve the diagnosis and monitoring of HIV infection in low- and medium-income countries, as well as in the training of local staff from these countries for their reference laboratories.

Bibliometrics

	Articles	Accum. IF	Mean IF	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2019	81	397.37	5.23	59	73	15	19
2020	104	413.83	4.36	72	69	19	18
2021	108	686.36	6.60	80	74	19	18
2022	114	856.67	8.16	85	75	15	13
2023	92	699.12	8.32	67	73	19	21
	499	3053.35	6.53	363	73	87	17

* Only original articles, editorial material, guidelines and reviews.

Networks and alliances

PRECICOLON-CM. Hacia la medicina de precisión en cáncer de colon: biomarcadores, microambiente tumoral y microbiota
CHAFEA-Consumers, Health, Agriculture and Food Executive Agency
Red de secuenciación de SARS-CoV-2